Home
Biz

Sun Pharma to acquire Concert Pharmaceuticals for US$576 mn

Concert is a late-stage biotechnology business that has finished evaluating the efficacy and safety of deuruxolitinib in adult patients with moderate to severe Alopecia Areata.

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login

ADVERTISEMENT

ADVERTISEMENT

Latest News

Student visa revocations stir panic across... 08 Apr, 2025
AANHPI woman makes 83 cents for... 08 Apr, 2025
Gautam Bhatia elected to Naperville Township... 08 Apr, 2025
US discusses tariffs, critical minerals, immigration... 08 Apr, 2025
ZEE5 Global announces digital premiere of... 08 Apr, 2025
Novo preparing for early launch of... 08 Apr, 2025
Visa cancelled, SEVIS gone? Here's what... 08 Apr, 2025

ADVERTISEMENT

E Paper

ADVERTISEMENT

Video

Related

Student visa revocations stir panic across US campuses

AANHPI woman makes 83 cents for every $1...

Gautam Bhatia elected to Naperville Township trustee board

US discusses tariffs, critical minerals, immigration with Pakistan

ZEE5 Global announces digital premiere of ‘Kingston’ on...

Novo preparing for early launch of weight-loss drug...

Visa cancelled, SEVIS gone? Here's what Indian students...

Request for Review and Accountability in UH Course...

Dr Srikanth Thudumu appointed AI director at IAAIR...

Stone Inlay, Stronger Futures: UNESCO Project Backs Agra's...

Bipartisan bill seeks to retain international STEM talent...

Ro Khanna honored with Publius Award for bipartisan...